YC. Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway.
(pre-miR-640; Ambion), precursor control (pre-miR-C; Ambion), or Cy3 Dye-labeled Pre-miR negative control (Ambion) were transfected with Lipofectamine RNAiMAX (Invitrogen), according to the manufacturer=s protocol. In the dual-luciferase assay, 10 nM of mimic miR-640 (mimic-640) or mimic control (mimic-C; Ribobio, Guangzhou, China) were transfected with Lipofectamine RNAiMAX (Invitrogen), according to the manufacturer=s protocol. To achieve siRNAmediated knockdown, HUVECs were transfected with hypoxia inducible factor 1-␣ (HIF1A) Silencer Validated siRNA (Ambion) and vascular endothelial growth factor receptor 2 (VEGFR2) Silencer Select siRNA (Ambion). A scrambled negative control siRNA (Ambion) was used as the control.
Adenovirus infection. To suppress the activity of HIF1A protein, DN-HIF1A (dominant-negative mutant of HIF1A) was constructed with a pcDNA3.1 backbone. The open reading frame encoding DN-HIF1A was a 1.1-kb fragment where the product lacked both the DNA-binding and transactivation domains of normal HIF1A protein.
HUVECs were infected with control virus with GFP (CV-GFP) or DN-HIF1A adenovirus at multiplicity of infection ϭ 10. The transcriptional activity of HIF1A was measured using a HIF1A Transcription Factor Assay Kit (Abnova, Taiwan, China).
Western blot analysis and ELISA. HUVECs were lysed in RIPA lysis buffer (Sigma, St. Louis, MO) for 20 min on ice. After centrifugation for 10 min at 12,000 g (4°C), the protein contents of the samples were determined using the BCA method. Equal amounts of proteins were loaded on SDS-polyacrylamide gels and blotted onto PVDF. Western blots were performed using antibodies against HIF1A (mouse monoclonal antibodies, 1:500; Abcam, Cambridge, UK), VEGFR2 (rabbit polyclonal antibodies, 1:1,000; CST, Boston, MA), p-mammalian target of rapamycin (p-mTOR; rabbit polyclonal antibodies against the phosphorylated Ser2448 site, 1:1,000; CST), mTOR (rabbit polyclonal antibodies, 1:500; Abcam), VEGF (rabbit polyclonal antibodies, 1:1,000; Santa Cruz Biotechnology, Santa Cruz, Dallas, TX), ACTIN (mouse monoclonal antibodies, 1:5,000), or GAPDH (mouse monoclonal antibodies, 1:3,000; CST). VEGF levels in the culture medium were measured in concentrated (by 10 times) culture medium using an ELISA kit provided by R&D Systems (Minneapolis, MN).
Real-time quantitative PCR. HUVECs were suspended in Trizol reagent (Invitrogen), and the total RNA was extracted according to the manufacturer=s instructions. Reverse transcription was performed using a Reverse Transcription Kit (Toyobo, Osaka, Japan). A SYBRGreen RT-PCR Kit from Toyobo was used for quantitative real-time quantitative PCR analysis with the StepOnePLUS Realtime PCR system (Applied Biosystems), according to the manufacturer's instructions. Gene-specific primers were used to detect human HIF1A (forward primer: 5=-CTACTAGTGCCACATCATCACCA-3=; reverse primer: 5=-GATTGCCCCAGCAGTCTACAT-3=) and VEGFR2 (forward primer: 5=-GTGATTGCCATGTTCTTCTGGC-3=; reverse primer: 5=-TTCATCTGGATCCATGACGA-3=). The samples were normalized against endogenous human GAPDH (forward primer: 5=-TGCCCCCATGTTCGTCA-3=; reverse primer: 5=-CTTGGCCAGGGGTGCTAA-3=), and fold changes were calculated using the formula 2
Ϫ⌬Ct . microRNA expression analysis. Total RNA was isolated from HUVECs, as described above. Reverse transcription of human mature miRNA was performed using a Taqman MicroRNA reverse transcription kit (Applied Biosystems). The miRNA expression levels in HUVECs were profiled using a Taqman MicroRNA RT-PCR kit (Applied Biosystems). The gene expression data were normalized against RNU6B, and fold changes were calculated using the formula 2
Ϫ⌬Ct . Cell proliferation assay. At 24 h after transfection, the complete medium was replaced with starvation medium (EBM with 1% FBS) for 24 h. The cells were collected, and the proliferation rate was determined with a CCK-8 kit (Roche, Basel, Switzerland).
Cell migration assay. Two types of cell migration assays were used. The Transwell migration assay was performed as described previously (5) . Briefly, HUVECs were suspended in 500 l EBM with 1% FBS and placed in the upper chamber of a modified Boyden chamber (2 ϫ 10 4 cells per chamber, pore size of 8 m; BD Biosciences, New York, NY) coated with 2.5 g/ml fibronectin. The chamber was placed in a 24-well culture dish containing EBM with 1% FBS. NaHS (50 M) was added to the bottom well. After incubation for 6 h at 37°C, the nonmigrating cells on the upper side of the chamber were mechanically removed by cotton swabs, and the remaining cells on the lower side were fixed with 4% formaldehyde. For quantification, the cells were stained with Crystal Violet Staining Solution (Beyotime, Haimeng, China). Cells on the bottom side of the chamber were counted manually in five random microscopic fields using ImageJ software [National Institutes of Health (NIH)].
In the scratch wound migration assay, confluent HUVECs were starved for 12 h before the experiments, and hydroxyurea (5 mM; Sigma) was used to prevent cell proliferation. The confluent cell monolayer was then scraped with a 1-ml pipette tip to generate scratch wounds and rinsed twice in EBM with 1% FBS. The cells were photographed immediately and 24 h later with an EVOS digital inverted microscope (AMG, Seattle, WA). The wound area was then analyzed using ImageJ.
In vitro tube-like network formation on Matrigel. Matrigel (BD Bioscience) basement membrane matrix was added to 24-well culture plates and incubated at 37°C until gelation occurred, as described previously (32) . HUVECs transfected with pre-miR-640, anti-miR-640 or nonspecific negative controls were cultured for 72 h before being plated onto Matrigel at 30,000 cells/well. The branching points and tube lengths were quantified after 18 h in five random microscopic fields.
Luciferase cloning and transfection. Synthetic oligonucleotides bearing the HIF1A 3=-UTR sequence or miR-640 predicted binding sites were cloned into the Dual-Luciferase reporter plasmid pmirGLO (Promega, Madison, WI), according to the manufacturer=s protocol. To quantify the luciferase activity, HEK293 cells were grown in 24-well plates until 60 -70% confluence. Next, 0.01 ng of the pmir-GLO plasmid were cotransfected with 10 nM of mimic-640, or mimic-C using Lipofectamine 2,000 (Invitrogen). The luciferase activity level was assessed after 24 h using a Dual-Luciferase Reporter 1,000 Assay System (Promega).
In vivo Matrigel plug assay. Animals were housed in pathogen-free barrier facilities and monitored regularly by the veterinary staff. C57BL/6 female mice were anesthetized with chloral hydrate (400 mg/kg) by intraperitoneal injection. Matrigel (500 l) was injected subcutaneously into the ventral side of mouse at day 0. Normal saline or 50 mol/kg NaHS were injected into the abdominal cavity per day. Matrigel plugs were harvested at day 6. Invading cells in Matrigel plugs were quantified based on the analysis of hematoxylin and eosin-stained section. To analyze hemoglobin, the Matrigel plugs were removed after 7 days and homogenized in 130 l deionized water. After centrifugation, the supernatant was collected, and a Drabkin assay (Sigma) was used to measure the hemoglobin concentration. The Drabkin's reagent consists of sodium bicarbonate, potassium cyanide, and potassium ferricyanide. Stock solutions of hemoglobin were used to generate a standard curve. The results were expressed relative to total weight of the Matrigel plugs. For immunostaining, sections were incubated with rabbit polyclonal anti-CD31 antibody (1:1,000; CST) overnight at 4°C, visualized by using A BC kits (Santa Cruz Biotechnology) with diaminobenzidine as substrate. This study conformed to the Guide for the Care and Use of Laboratory Animals published by the NIH of the United States, and it was approved by the Ethics Committee for Experimental Research, Fudan University Shanghai Medical College.
Statistical analysis. The data are expressed as means Ϯ SE. Two treatment groups were compared using the Student=s t-test (SPSS). Multiple group comparisons were tested by one-way ANOVA (post hoc analysis). Results were considered statistically significant when P Ͻ 0.05.
RESULTS

H 2 S promoted angiogenesis in vitro and in vivo.
HUVECs and HMEC-1 cells were treated with vehicle or NaHS (an H 2 S donor, 50 M) for 24 h. The CCK-8 assay showed that H 2 S stimulated cell viability (Fig. 1A) . Moreover, we observed the proangiogenic effect of H 2 S in both HUVECs and HMEC-1 cells in the scratch wound healing assay (Fig. 1 , B and C). The effect was confirmed by the Transwell migration assay (Fig.  1D ) and tube formation assay of vascular ECs in vitro ( Fig. 1E ) based on crossing point numbers and tube length. In addition, H 2 S increased the neovascularization and the hemoglobin content in Matrigel plugs in vivo (Fig. 1F) . To quantify the density of capillaries, we stained the plug sections with anti-CD31 antibody, and the result confirmed the proangiogenic effect of H 2 S (Fig. 1G) . Overall, these results suggest that H 2 S is a proangiogenic gaseous factor in vitro and in vivo.
H 2 S decreased the levels of miR-640 via the VEGFR2-mTOR pathway. miRNA microarray profiling studies were performed by testing total RNA extracted from NaHS-treated (50 M) HUVECs to identify whether miRNAs are involved in the proangiogenic effect of H 2 S. The results showed that the level of 12 miRNAs increased or decreased at least by twofold (Fig.  1H) . We then validated the microarray results using quantitative PCR analysis. Interestingly, the level of miR-640, a miRNA that has never been linked with EC function and was believed to participate in tumorigenesis, was reduced by H 2 S in HUVECs ( Fig. 2A) and HMEC-1 cells (Fig. 2B) .
To determine the underlying molecular mechanisms, we further investigated the signaling pathways involved in the H 2 S-mediated downregulation of miR-640. VEGFR2 is reported to function as an H 2 S-targeting receptor protein and a specific molecular switch for H 2 S in vascular ECs (28), we therefore decreased the levels of VEGFR2 mRNA and protein using a specific siRNA (Fig. 2, C and D) ; we then determined whether VEGFR2 was involved in this downregulation process. As expected, siRNA-mediated knockdown of VEGFR2 led to an obvious suppression of angiogenesis induced by H 2 S, according to the in vitro scratch wound healing assay (Fig. 2,  E, F, and G) , Transwell migration assay (Fig. 2, H and I) , and vascular tube formation assay (Fig. 2, J and K) . In those assays, VEGF acted as a positive control. Interestingly, the miR-640 repression caused by H 2 S was blocked by VEGFR2 knockdown (Fig. 2L) . Next, to understand how angiogenesis increased when VEGFR2 was knocked down, we performed the CCK-8 assay and observed that cell viability increased significantly (Fig. 3A) . Meanwhile, the phosphorylation of VEGFR1 (Fig. 3B ) and the level of VEGF in the ECs (Fig. 3C) increased, and the level of VEGF protein remained steady in the culture medium (Fig. 3D) .
As an essential molecule of VEGFR2 downstream signaling, the mTOR plays an important role in regulating miR-640. Thus, through experimentation, we found that H 2 S increased the phosphorylation of mTOR in a time-dependent manner, but it had no effect on the level of mTOR protein (Fig. 4A) . The NaHS-induced phosphorylation of mTOR was blunted in vascular ECs after VEGFR2 was knocked down (Fig. 4B) . However, the inhibition of mTOR by rapamycin (Fig. 4C) , a classic mTOR inhibitor, decreased cell migration in the scratch wound healing assay (Fig. 4, D and E) . The H 2 S-induced migration and repression of miR-640 were both blocked by treatment with rapamycin (Fig. 4F) .
miR-640 inhibited the proangiogenic effect of H 2 S. To assess the potential role of miR-640 in endothelial angiogenesis, we examined its effect in gain and loss of function experiments through transfection with the precursor of miR-640 (pre-miR-640) and the antisense strand of miR-640 (anti-miR-640). The overexpression of miR-640 after transfection with pre-miR-640 increased miR-640 levels (Fig. 5A ), whereas transfection with anti-miR-640 decreased miR-640 levels (Fig. 5, B and C) . Meanwhile, the overexpression of miR-640 decreased in vitro angiogenesis in response to H 2 S in the scratch wound healing assay (Fig. 5D ), Transwell migration assay (Fig. 5E) , and vascular tube formation assay (Fig. 5, F and G) . In contrast, the inhibition of miR-640 (anti-miR-640, 75 nM) had a similar proangiogenic effect to NaHS treatment (Fig. 5, H-K) , whereas considerable miR-640 inhibition (anti-miR-640, 150 nM) con- cealed the proangiogenic effect of H 2 S (Fig. 5, L-O) . Overall, these results indicated that miR-640 can inhibit the proangiogenic effect of H 2 S.
miR-640 inhibited angiogenesis by downregulating HIF1A. To identify potential targets for miR-640 in ECs, we employed three databases, the TargetScan (http://www.targetscan.org), miRDB (http://mirdb.org), and miRanda (http://www.microrna.org) to make a prediction. miRDB and miRanda predicted HIF1A as a target for miR-640 because of the presence of three binding sites in the 3=-UTR of the HIF1A mRNA (see Fig. 8 , A-C). We found that the overexpression of miR-640 in HEK293 cells inhibited the activity of a dual-luciferase reporter plasmid containing the 3=-UTR of HIF1A, whereas the inhibition of miR-640 increased its activity (Fig. 6A) . We also observed that in RF/6A ECs, the overexpression of miR-640 suppressed the relative luciferase activity of recombinant dualluciferase reporter plasmid containing the predicted binding site 1 (174 -194) of HIF1A 3=-UTR, which meant that site 1 (174 -194) was the main binding site of miR-640 (Fig. 6B ). In accordance with the dual-luciferase results, H 2 S not only increased the transcriptional activity of HIF1A (Fig. 6C) but also increased the level of HIF1A protein (Fig. 6D) . In addition, the HIF1A protein level significantly increased after inhibiting miR-640 (Fig. 6E ). In contrast, the level of HIF1A protein was reduced by miR-640 overexpression in ECs (Fig. 6E) . Moreover, the level of VEGFR2 protein was upregulated in cells transfected with exogenous pre-miR-640, whereas no change was observed in cells with antimiR-640 (Fig. 6F ). In addition, the level of VEGF protein decreased in cells and in their culture medium after the overexpression of miR-640; this is confirmed by the result of miR-640 inhibition (Fig. 6, G and H) .
To explore the effect of HIF1A, we transfected cells with an adenovirus containing DN-HIF1A or an siRNA against HIF1A. The results showed decreased activity of HIF1A (Fig.  7A ) and lower protein levels (Fig. 7B) , respectively. Adenoviral infection with DN-HIF1A decreased cell migration and abolished H 2 S-induced cell migration in the scratch wound healing assay (Fig. 7C) . HIF1A knockdown by siRNA also blunted the proangiogenic effects of H 2 S (Fig. 7, D-G) . We also found that the level of VEGFR2 protein was upregulated in cells that have been transfected with siRNA against HIF1A (Fig. 7H) , whereas the levels of VEGF protein decreased in cells (Fig. 7I) as well as in their culture medium (Fig. 7J) ; these were similar to the effects of miR-640 overexpression. Overall, these results indicated that HIF1A is a target for miR-640 in HUVECs and it may promote the process of angiogenesis in vitro.
DISCUSSION
Since our previous study reported a proangiogenic role of H 2 S (5), H 2 S and its effects have been investigated in various physiological/pathophysiological models (21, 22, 31) . Molecules that serve as direct targets for H 2 S have been identified, such as VEGFR2 (27) and EGFR (8) . However, the downstream signaling networks of H 2 S remain largely unknown (9).
Here we identified 12 miRNAs that may mediate the proangiogenic role of H 2 S. Some miRNAs, such as Let7-f, miR-27b, miR-130a, miR-221, and miR-222, have been reported to be involved in EC function or angiogenesis (29) . However, only a few studies have tested the correlation between H 2 S and miRNAs during angiogenesis. Huang et al. (11) found that miR-34a mediated the liver-protective effect of H 2 S against ischemia-reperfusion injury in young and old rats via the Nrf-2 pathway. Similarly, H 2 S protected cardiomyocytes from myocardial infarction by increasing the levels of cystathionine-␥-lyase (CSE), an endogenously generated enzyme of H 2 S, and H 2 S by silencing the miR-30 family (24) . In addition, the stimulation of Bcl-2 was caused by miR-1 downregulation (15) .
In the present study, we found that the expression of miR-640 decreased in HUVECs after NaHS treatment. We also identified miR-640 as a suppressor for the migration and tube formation of HUVECs. Thus, for the first time, our results suggested that miR-640 plays an important role in H 2 S-mediated angiogenesis. Two previous studies have described the physiological role of miR-640: one showed that patients with ovarian carcinoma who showed higher miR-640 levels in tumors have better survival rate than those who have lower miR-640 levels (18) , and another study associated miR-640 with the progression of chronic lymphocytic leukemia without details (30) . Our results provide new insights into the role of miR-640 in angiogenesis.
Previously, we reported that VEGFR2 acts as a direct target molecule for H 2 S in vascular ECs (27) . H 2 S promoted cell migration in both the scrambled siRNA and VEGFR2 siRNA transfecting groups in wound healing assays and Transwell migration assays. This effect is mitigated in VEGFR2 knockdown cells. The high cell viability and VEGFR1 activation after VEGFR2 knockdown may contribute to the increase of cell migration. It should be noted that the beneficial effects of VEGFR2 knockdown are not in conflict with the fact that the major proangiogenic effect of VEGF is a result of its binding to VEGFR2. Because the signaling pathways to promote angiogenesis mediated by VEGFR2 and VEGFR1 were different (4), these two receptors may complement each other in H 2 Sinduced angiogenesis. NaHS treatment could activate the phosphoinositide 3-kinase/Akt axis and enhance the phosphorylation of members of the mitogen-activated protein kinase pathway (31) . In the present study, we showed that mTOR, a major downstream protein in the VEGFR2 pathway, plays an important role in H 2 S-mediated angiogenesis. It is known that mTOR signaling controls the growth, metabolism, and energy homeostasis of cells in a cell-autonomous manner (2) . mTOR serves as a downstream effector of Akt, and it is activated indirectly by activated Akt (12) . Several agents have been developed to inhibit mTOR signaling in tumor cells, and these drugs have effects on angiogenesis as well as on the proliferation and survival of tumors (16) . Our present study showed that H 2 S induced a time-dependent increase in mTOR phosphorylation in ECs, thereby suggesting a role for mTOR in H 2 S-induced effects. Furthermore, miR-640 was not inhibited by NaHS in mTOR-inhibited cells. H 2 S-induced migration of ECs was also blunted by mTOR inhibitors. These findings suggest that mTOR is involved in H 2 S-stimulated angiogenesis by regulating miR-640.
To further examine how the proangiogenic signals of H 2 S were transduced downstream of miR-640, genes targeted by miR-640 were also investigated. Computational analyses predicted three putative miR-640 binding sites in the 3=-UTR of HIF1A. Our subsequent study demonstrated that miR-640 could directly target the 3=-UTR of HIF1A, and its expression is negatively associated with the expression of HIF1A mRNA. In addition, we identified that site 1 (174 -194) in the HIF1A 3=-UTR was the main binding site of miR-640 in ECs. Moreover, significant downregulation of the level of HIF1A protein was observed after miR-640 overexpression, whereas miR-640 inhibition upregulated the level of HIF1A protein.
As a regulatory subunit of HIF1, HIF1A mRNAs are constitutively expressed and were not altered when exposed to hypoxia, whereas its protein levels were dramatically elevated (14) . Under normoxia, the pVHL-mediated ubiquitin protease pathway rapidly degraded HIF1A proteins; whereas under hypoxia, HIF1A protein degradation was prevented and HIF1A levels accumulated to associate with HIF1B to promote target genes (10) . HIF1A was reported to contribute to H 2 S-mediated cardiac protection (20) and anti-hepatocellular carcinoma (19) . HIF1A was also involved in the proangiogenic effects of H 2 S (28). In the present study, we found that protein levels and transcriptional activity of HIF1A were upregulated by NaHS treatment. Moreover, the downregulation of HIF1A by DN-HIF1A or siRNA decreased the migration of ECs in the scratch wound healing assay and also abolished H 2 S-induced cell migration. These results indicated that H 2 S might promote angiogenesis by repressing miR-640 and leading to an increase of HIF1A protein. As a regulatory subunit of HIF1, HIF1A regulates a variety of angiogenic growth factors, including VEGF, angiopoietin 2, stromal-derived factor 1, and a stem cell factor, via transcriptional modulation (6, 23) . We found that HIF1A knockdown or miR-640 overexpression downregulated VEGF levels in both cells and their culture medium, whereas the level of VEGFR2 protein was slightly upregulated, which may be due to an unknown negative feedback (Fig. 8, D  and E) . Stable H 2 S levels may contribute physiologically to the feedback effects from VEGF on HIF1A. The concentration of endogenous H 2 S is determined mainly by three enzymes: cystathionine-␤-synthase, CSE, and mercaptopyruvate sulfurtransferase (31). The homeostasis of endogenous H 2 S in this feedback system is a promising area for future research.
In the present study, we examined the miR-640-mediated pathway, which may contribute to the proangiogenic effect of H 2 S. However, this does not exclude the potential roles of other miRNAs in these signaling networks. Indeed, we consider that miRNAs regulated by H 2 S may have various roles in the process of angiogenesis and other miRNAs may also regulate the effects of H 2 S.
In conclusion, we revealed a new role for miR-640 in mediating the proangiogenic role of H 2 S. H 2 S signals are transduced through the VEGFR2-mTOR pathway to regulate miR-640 expression, while 3=-UTR of HIF1A serves as a direct target for miR-640, which subsequently transduces the proangiogenic signals of H 2 S. The study sheds a light to clarify the signaling mechanisms underlying the cardiovascular role of H 2 S.
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